Global Pemphigus Vulgaris Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

TABLE 1 GLOBAL PEMPHIGUS VULGARIS MARKET, PATENT ANALYSIS

TABLE 2 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE GLOBAL PEMPHIGUS VULGARIS MARKET

TABLE 3 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE GLOBAL PEMPHIGUS VULGARIS MARKET

TABLE 4 SURVIVAL RATES IN PEMPHIGUS VULGARIS

TABLE 5 GLOBAL PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 6 GLOBAL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2028-2032 (USD MILLION)

TABLE 7 GLOBAL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 8 GLOBAL STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 9 GLOBAL ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 10 GLOBAL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 11 GLOBAL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 12 GLOBAL DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 13 GLOBAL DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 14 GLOBAL PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 15 GLOBAL ADULTS IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 16 GLOBAL GERIATRIC IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 17 GLOBAL PEDIATRIC IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 18 GLOBAL PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 19 GLOBAL HOSPITALS IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 20 GLOBAL SPECIALTY CLINICS IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 21 GLOBAL RESEARCH INSTITUTES IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 22 GLOBAL OTHERS IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 23 GLOBAL PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 24 GLOBAL HOSPITALS PHARMACY IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 25 GLOBAL RETAIL PHARMACY IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 26 GLOBAL ONLINE PHARMACY IN PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 27 GLOBAL PEMPHIGUS VULGARIS MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 28 NORTH AMERICA PEMPHIGUS VULGARIS MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 29 NORTH AMERICA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 30 NORTH AMERICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 31 NORTH AMERICA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 32 NORTH AMERICA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 33 NORTH AMERICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 34 NORTH AMERICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 35 NORTH AMERICA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 36 NORTH AMERICA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 37 NORTH AMERICA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 38 NORTH AMERICA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 39 U.S. PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 40 U.S. TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 41 U.S. STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 42 U.S. ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 43 U.S. TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 44 U.S. TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 45 U.S. DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 46 U.S. PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 47 U.S. PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 48 U.S. PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 49 CANADA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 50 CANADA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 51 CANADA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 52 CANADA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 53 CANADA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 54 CANADA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 55 CANADA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 56 CANADA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 57 CANADA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 58 CANADA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 59 MEXICO PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 60 MEXICO TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 61 MEXICO STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 62 MEXICO ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 63 MEXICO TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 64 MEXICO TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 65 MEXICO DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 66 MEXICO PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 67 MEXICO PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 68 MEXICO PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 69 EUROPE PEMPHIGUS VULGARIS MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 70 EUROPE PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 71 EUROPE TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 72 EUROPE STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 73 EUROPE ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 74 EUROPE TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 75 EUROPE TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 76 EUROPE DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 77 EUROPE PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 78 EUROPE PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 79 EUROPE PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 80 GERMANY PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 81 GERMANY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 82 GERMANY STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 83 GERMANY ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 84 GERMANY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 85 GERMANY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 86 GERMANY DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 87 GERMANY PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 88 GERMANY PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 89 GERMANY PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 90 U.K. PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 91 U.K. TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 92 U.K. STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 93 U.K. ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 94 U.K. TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 95 U.K. TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 96 U.K. DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 97 U.K. PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 98 U.K. PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 99 U.K. PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 100 FRANCE PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 101 FRANCE TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 102 FRANCE STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 103 FRANCE ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 104 FRANCE TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 105 FRANCE TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 106 FRANCE DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 107 FRANCE PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 108 FRANCE PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 109 FRANCE PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 110 ITALY PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 111 ITALY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 112 ITALY STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 113 ITALY ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 114 ITALY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 115 ITALY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 116 ITALY DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 117 ITALY PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 118 ITALY PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 119 ITALY PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 120 SPAIN PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 121 SPAIN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 122 SPAIN STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 123 SPAIN ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 124 SPAIN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 125 SPAIN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 126 SPAIN DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 127 SPAIN PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 128 SPAIN PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 129 SPAIN PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 130 SWITZERLAND PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 131 SWITZERLAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 132 SWITZERLAND STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 133 SWITZERLAND ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 134 SWITZERLAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 135 SWITZERLAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 136 SWITZERLAND DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 137 SWITZERLAND PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 138 SWITZERLAND PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 139 SWITZERLAND PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 140 TURKEY PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 141 TURKEY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 142 TURKEY STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 143 TURKEY ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 144 TURKEY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 145 TURKEY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 146 TURKEY DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 147 TURKEY PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 148 TURKEY PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 149 TURKEY PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 150 RUSSIA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 151 RUSSIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 152 RUSSIA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 153 RUSSIA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 154 RUSSIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 155 RUSSIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 156 RUSSIA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 157 RUSSIA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 158 RUSSIA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 159 RUSSIA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 160 BELGIUM PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 161 BELGIUM TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 162 BELGIUM STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 163 BELGIUM ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 164 BELGIUM TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 165 BELGIUM TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 166 BELGIUM DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 167 BELGIUM PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 168 BELGIUM PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 169 BELGIUM PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 170 NETHERLANDS PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 171 NETHERLANDS TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 172 NETHERLANDS STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 173 NETHERLANDS ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 174 NETHERLANDS TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 175 NETHERLANDS TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 176 NETHERLANDS DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 177 NETHERLANDS PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 178 NETHERLANDS PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 179 NETHERLANDS PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 180 DENMARK PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 181 DENMARK TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 182 DENMARK STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 183 DENMARK ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 184 DENMARK TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 185 DENMARK TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 186 DENMARK DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 187 DENMARK PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 188 DENMARK PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 189 DENMARK PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 190 NORWAY PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 191 NORWAY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 192 NORWAY STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 193 NORWAY ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 194 NORWAY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 195 NORWAY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 196 NORWAY DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 197 NORWAY PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 198 NORWAY PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 199 NORWAY PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 200 FINLAND PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 201 FINLAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 202 FINLAND STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 203 FINLAND ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 204 FINLAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 205 FINLAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 206 FINLAND DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 207 FINLAND PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 208 FINLAND PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 209 FINLAND PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 210 POLAND PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 211 POLAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 212 POLAND STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 213 POLAND ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 214 POLAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 215 POLAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 216 POLAND DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 217 POLAND PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 218 POLAND PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 219 POLAND PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 220 SWEDEN PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 221 SWEDEN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 222 SWEDEN STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 223 SWEDEN ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 224 SWEDEN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 225 SWEDEN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 226 SWEDEN DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 227 SWEDEN PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 228 SWEDEN PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 229 SWEDEN PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 230 REST OF EUROPE PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 231 ASIA-PACIFIC PEMPHIGUS VULGARIS MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 232 ASIA-PACIFIC PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 233 ASIA-PACIFIC TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 234 ASIA-PACIFIC STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 235 ASIA-PACIFIC ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 236 ASIA-PACIFIC TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 237 ASIA-PACIFIC TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 238 ASIA-PACIFIC DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 239 ASIA-PACIFIC PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 240 ASIA-PACIFIC PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 241 ASIA-PACIFIC PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 242 CHINA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 243 CHINA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 244 CHINA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 245 CHINA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 246 CHINA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 247 CHINA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 248 CHINA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 249 CHINA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 250 CHINA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 251 CHINA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 252 INDIA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 253 INDIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 254 INDIA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 255 INDIA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 256 INDIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 257 INDIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 258 INDIA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 259 INDIA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 260 INDIA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 261 INDIA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 262 SOUTH KOREA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 263 SOUTH KOREA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 264 SOUTH KOREA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 265 SOUTH KOREA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 266 SOUTH KOREA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 267 SOUTH KOREA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 268 SOUTH KOREA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 269 SOUTH KOREA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 270 SOUTH KOREA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 271 SOUTH KOREA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 272 MALAYSIA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 273 MALAYSIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 274 MALAYSIA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 275 MALAYSIA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 276 MALAYSIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 277 MALAYSIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 278 MALAYSIA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 279 MALAYSIA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 280 MALAYSIA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 281 MALAYSIA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 282 JAPAN PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 283 JAPAN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 284 JAPAN STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 285 JAPAN ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 286 JAPAN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 287 JAPAN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 288 JAPAN DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 289 JAPAN PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 290 JAPAN PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 291 JAPAN PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 292 AUSTRALIA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 293 AUSTRALIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 294 AUSTRALIA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 295 AUSTRALIA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 296 AUSTRALIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 297 AUSTRALIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 298 AUSTRALIA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 299 AUSTRALIA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 300 AUSTRALIA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 301 AUSTRALIA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 302 SINGAPORE PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 303 SINGAPORE TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 304 SINGAPORE STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 305 SINGAPORE ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 306 SINGAPORE TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 307 SINGAPORE TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 308 SINGAPORE DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 309 SINGAPORE PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 310 SINGAPORE PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 311 SINGAPORE PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 312 THAILAND PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 313 THAILAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 314 THAILAND STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 315 THAILAND ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 316 THAILAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 317 THAILAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 318 THAILAND DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 319 THAILAND PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 320 THAILAND PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 321 THAILAND PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 322 INDONESIA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 323 INDONESIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 324 INDONESIA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 325 INDONESIA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 326 INDONESIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 327 INDONESIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 328 INDONESIA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 329 INDONESIA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 330 INDONESIA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 331 INDONESIA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 332 NEW ZEALAND PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 333 NEW ZEALAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 334 NEW ZEALAND STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 335 NEW ZEALAND ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 336 NEW ZEALAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 337 NEW ZEALAND TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 338 NEW ZEALAND DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 339 NEW ZEALAND PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 340 NEW ZEALAND PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 341 NEW ZEALAND PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 342 TAIWAN PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 343 TAIWAN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 344 TAIWAN STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 345 TAIWAN ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 346 TAIWAN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 347 TAIWAN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 348 TAIWAN DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 349 TAIWAN PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 350 TAIWAN PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 351 TAIWAN PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 352 PHILIPPINES PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 353 PHILIPPINES TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 354 PHILIPPINES STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 355 PHILIPPINES ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 356 PHILIPPINES TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 357 PHILIPPINES TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 358 PHILIPPINES DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 359 PHILIPPINES PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 360 PHILIPPINES PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 361 PHILIPPINES PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 362 HONG KONG PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 363 HONG KONG TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 364 HONG KONG STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 365 HONG KONG ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 366 HONG KONG TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 367 HONG KONG TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 368 HONG KONG DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 369 HONG KONG PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 370 HONG KONG PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 371 HONG KONG PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 372 REST OF ASIA-PACIFIC PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 373 SOUTH AMERICA PEMPHIGUS VULGARIS MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 374 SOUTH AMERICA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 375 SOUTH AMERICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 376 SOUTH AMERICA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 377 SOUTH AMERICA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 378 SOUTH AMERICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 379 SOUTH AMERICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 380 SOUTH AMERICA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 381 SOUTH AMERICA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 382 SOUTH AMERICA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 383 SOUTH AMERICA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 384 BRAZIL PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 385 BRAZIL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 386 BRAZIL STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 387 BRAZIL ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 388 BRAZIL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 389 BRAZIL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 390 BRAZIL DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 391 BRAZIL PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 392 BRAZIL PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 393 BRAZIL PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 394 ARGENTINA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 395 ARGENTINA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 396 ARGENTINA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 397 ARGENTINA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 398 ARGENTINA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 399 ARGENTINA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 400 ARGENTINA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 401 ARGENTINA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 402 ARGENTINA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 403 ARGENTINA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 404 COLOMBIA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 405 COLOMBIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 406 COLOMBIA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 407 COLOMBIA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 408 COLOMBIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 409 COLOMBIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 410 COLOMBIA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 411 COLOMBIA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 412 COLOMBIA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 413 COLOMBIA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 414 PERU PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 415 PERU TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 416 PERU STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 417 PERU ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 418 PERU TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 419 PERU TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 420 PERU DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 421 PERU PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 422 PERU PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 423 PERU PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 424 URUGUAY PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 425 URUGUAY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 426 URUGUAY STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 427 URUGUAY ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 428 URUGUAY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 429 URUGUAY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 430 URUGUAY DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 431 URUGUAY PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 432 URUGUAY PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 433 URUGUAY PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 434 ECUADOR PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 435 ECUADOR TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 436 ECUADOR STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 437 ECUADOR ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 438 ECUADOR TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 439 ECUADOR TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 440 ECUADOR DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 441 ECUADOR PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 442 ECUADOR PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 443 ECUADOR PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 444 PARAGUAY PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 445 PARAGUAY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 446 PARAGUAY STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 447 PARAGUAY ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 448 PARAGUAY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 449 PARAGUAY TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 450 PARAGUAY DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 451 PARAGUAY PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 452 PARAGUAY PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 453 PARAGUAY PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 454 VENEZUELA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 455 VENEZUELA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 456 VENEZUELA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 457 VENEZUELA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 458 VENEZUELA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 459 VENEZUELA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 460 VENEZUELA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 461 VENEZUELA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 462 VENEZUELA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 463 VENEZUELA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 464 BOLIVIA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 465 BOLIVIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 466 BOLIVIA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 467 BOLIVIA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 468 BOLIVIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 469 BOLIVIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 470 BOLIVIA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 471 BOLIVIA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 472 BOLIVIA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 473 BOLIVIA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 474 REST OF SOUTH AMERICA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 475 MIDDLE EAST AND AFRICA PEMPHIGUS VULGARIS MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 476 MIDDLE EAST AND AFRICA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 477 MIDDLE EAST AND AFRICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 478 MIDDLE EAST AND AFRICA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 479 MIDDLE EAST AND AFRICA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 480 MIDDLE EAST AND AFRICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 481 MIDDLE EAST AND AFRICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 482 MIDDLE EAST AND AFRICA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 483 MIDDLE EAST AND AFRICA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 484 MIDDLE EAST AND AFRICA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 485 MIDDLE EAST AND AFRICA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 486 SAUDI ARABIA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 487 SAUDI ARABIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 488 SAUDI ARABIA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 489 SAUDI ARABIA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 490 SAUDI ARABIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 491 SAUDI ARABIA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 492 SAUDI ARABIA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 493 SAUDI ARABIA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 494 SAUDI ARABIA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 495 SAUDI ARABIA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 496 EGYPT PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 497 EGYPT TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 498 EGYPT STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 499 EGYPT ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 500 EGYPT TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 501 EGYPT TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 502 EGYPT DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 503 EGYPT PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 504 EGYPT PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 505 EGYPT PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 506 U.A.E. PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 507 U.A.E. TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 508 U.A.E. STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 509 U.A.E. ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 510 U.A.E. TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 511 U.A.E. TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 512 U.A.E. DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 513 U.A.E. PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 514 U.A.E. PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 515 U.A.E. PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 516 SOUTH AFRICA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 517 SOUTH AFRICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 518 SOUTH AFRICA STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 519 SOUTH AFRICA ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 520 SOUTH AFRICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 521 SOUTH AFRICA TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 522 SOUTH AFRICA DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 523 SOUTH AFRICA PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 524 SOUTH AFRICA PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 525 SOUTH AFRICA PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 526 ISRAEL PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 527 ISRAEL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 528 ISRAEL STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 529 ISRAEL ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 530 ISRAEL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 531 ISRAEL TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 532 ISRAEL DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 533 ISRAEL PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 534 ISRAEL PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 535 ISRAEL PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 536 BAHRAIN PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 537 BAHRAIN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 538 BAHRAIN STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 539 BAHRAIN ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 540 BAHRAIN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 541 BAHRAIN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 542 BAHRAIN DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 543 BAHRAIN PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 544 BAHRAIN PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 545 BAHRAIN PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 546 KUWAIT PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 547 KUWAIT TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 548 KUWAIT STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 549 KUWAIT ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 550 KUWAIT TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 551 KUWAIT TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 552 KUWAIT DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 553 KUWAIT PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 554 KUWAIT PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 555 KUWAIT PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 556 OMAN PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 557 OMAN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 558 OMAN STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 559 OMAN ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 560 OMAN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 561 OMAN TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 562 OMAN DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 563 OMAN PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 564 OMAN PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 565 OMAN PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 566 QATAR PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)

TABLE 567 QATAR TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 568 QATAR STEROID-SPARING IMMUNOSUPPRESSANT DRUGS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 569 QATAR ANTI-INFLAMMATORY AGENTS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 570 QATAR TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 571 QATAR TREATMENT IN PEMPHIGUS VULGARIS MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 572 QATAR DIAGNOSIS IN PEMPHIGUS VULGARIS MARKET, BY TYPE, 2018-2032 (USD MILLION)

TABLE 573 QATAR PEMPHIGUS VULGARIS MARKET, BY POPULATION TYPE, 2018-2032 (USD MILLION)

TABLE 574 QATAR PEMPHIGUS VULGARIS MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 575 QATAR PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 576 REST OF MIDDLE EAST AND AFRICA PEMPHIGUS VULGARIS MARKET, BY DIAGNOSIS AND TREATMENT, 2018-2032 (USD MILLION)